Telo Genomics

Toronto, Canada

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

$1.2M raised

Jan 2026

Post-IPO Debt

Biotechnology Oncology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Telo Genomics

How much funding has Telo Genomics raised?

Telo Genomics has raised $1.2M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2026.

Where is Telo Genomics headquartered?

Telo Genomics is headquartered in Toronto, Canada.

What does Telo Genomics do?

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

What stage is Telo Genomics at?

Telo Genomics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 19, 2026.

MLA

"Telo Genomics — Funding & Investors." VCBacked, January 19, 2026, https://www.vcbacked.co/company/telo-genomics. Accessed July 2, 2026.

APA

VCBacked. (2026). Telo Genomics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/telo-genomics

Wikipedia (cite web)

{{cite web |title=Telo Genomics — Funding & Investors |url=https://www.vcbacked.co/company/telo-genomics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 19, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K